Academic Content and Language Evaluation of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4853)
All Articles published online
|
Publishing Process of This Article
|
Dec 15, 2021 (publication date) through Dec 3, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Liu ZN, Wang YK, Zhang L, Jia YN, Fei S, Ying XJ, Zhang Y, Li SX, Sun Y, Li ZY, Ji JF. Comparison of tumor regression grading systems for locally advanced gastric adenocarcinoma after neoadjuvant chemotherapy. World J Gastrointest Oncol 2021; 13(12): 2161-2179 [PMID: 35070049 DOI: 10.4251/wjgo.v13.i12.2161] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9366/full/v13/i12/2161.htm |
| Number | Citing Articles |
| 1 |
Feiyu Meng, Yang Yang, Xinyu Wang, Fenglin Cai, Han Liang, Rupeng Zhang, Jingyu Deng. Imaging lymph node regression can predict the pathological tumor regression grade in gastric cancer after neoadjuvant treatment. Surgery 2023; 174(4): 836 doi: 10.1016/j.surg.2023.07.003
|
| 2 |
Theresa Hiltner, Noémi Szörenyi, Meike Kohlruss, Alexander Hapfelmeier, Anna-Lina Herz, Julia Slotta-Huspenina, Moritz Jesinghaus, Alexander Novotny, Sebastian Lange, Katja Ott, Wilko Weichert, Gisela Keller. Significant Tumor Regression after Neoadjuvant Chemotherapy in Gastric Cancer, but Poor Survival of the Patient? Role of MHC Class I Alterations. Cancers 2023; 15(3): 771 doi: 10.3390/cancers15030771
|
| 3 |
Rongyuan Wei, Junquan Song, Xuanjun Liu, Shiying Huo, Chenchen Liu, Xiaowen Liu. Immunosuppressive MFAP2+ cancer associated fibroblasts conferred unfavorable prognosis and therapeutic resistance in gastric cancer. Cellular Oncology 2024; 47(1): 55 doi: 10.1007/s13402-023-00849-y
|
| 4 |
Pengfei Su, Yingjing Zhang, Tian Yu, Lin Jiang, Weiming Kang, Yuqin Liu, Jianchun Yu. Comparison of the predictive value of pathological response at primary tumor and lymph node status after neoadjuvant chemotherapy in locally advanced gastric cancer. Clinical and Translational Oncology 2023; 25(8): 2462 doi: 10.1007/s12094-023-03130-8
|
| 5 |
Efstathios Kavvadas. C3d(g), iron nanoparticles, hemin and cytochrome c may induce oxidative cytotoxicity in tumors and reduce tumor-associated myeloid cells-mediated immunosuppression. Medical Hypotheses 2022; 167: 110944 doi: 10.1016/j.mehy.2022.110944
|
| 6 |
Magnus Kock am Brink, Laura Sophie Dunst, Hans-Michael Behrens, Sandra Krüger, Thomas Becker, Christoph Röcken. Intratumoral heterogeneity affects tumor regression and Ki67 proliferation index in perioperatively treated gastric carcinoma. British Journal of Cancer 2023; 128(2): 375 doi: 10.1038/s41416-022-02047-3
|
| 7 |
Sebastian Kobiałka, Katarzyna Sędłak, Zuzanna Pelc, Radosław Mlak, Yutaka Endo, Paweł Bogacz, Andrzej Kurylcio, Wojciech P. Polkowski, Timothy M. Pawlik, Karol Rawicz-Pruszyński. Hyperthermic Intraperitoneal Chemotherapy (HIPEC), Oncological Outcomes and Long-Term Survival among Patients with Gastric Cancer and Limited Peritoneal Disease Progression after Neoadjuvant Chemotherapy. Journal of Clinical Medicine 2023; 13(1): 161 doi: 10.3390/jcm13010161
|